ID   DHB12_RAT               Reviewed;         312 AA.
AC   Q6P7R8; Q9Z1B9;
DT   05-SEP-2006, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2004, sequence version 1.
DT   02-OCT-2024, entry version 145.
DE   RecName: Full=Very-long-chain 3-oxoacyl-CoA reductase {ECO:0000305};
DE            EC=1.1.1.330 {ECO:0000250|UniProtKB:Q53GQ0};
DE   AltName: Full=17-beta-hydroxysteroid dehydrogenase 12 {ECO:0000250|UniProtKB:Q53GQ0};
DE            Short=17-beta-HSD 12 {ECO:0000250|UniProtKB:Q53GQ0};
DE   AltName: Full=3-ketoacyl-CoA reductase {ECO:0000250|UniProtKB:Q53GQ0};
DE            Short=KAR {ECO:0000250|UniProtKB:Q53GQ0};
DE   AltName: Full=Estradiol 17-beta-dehydrogenase 12 {ECO:0000250|UniProtKB:Q53GQ0};
DE            EC=1.1.1.62 {ECO:0000250|UniProtKB:Q53GQ0};
GN   Name=Hsd17b12 {ECO:0000312|RGD:708367};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Trzyna W.C., Gabbeta V., McHugh K.M.;
RL   Submitted (DEC-1996) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Pituitary anterior lobe;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: Catalyzes the second of the four reactions of the long-chain
CC       fatty acids elongation cycle. This endoplasmic reticulum-bound
CC       enzymatic process, allows the addition of two carbons to the chain of
CC       long- and very long-chain fatty acids/VLCFAs per cycle. This enzyme has
CC       a 3-ketoacyl-CoA reductase activity, reducing 3-ketoacyl-CoA to 3-
CC       hydroxyacyl-CoA, within each cycle of fatty acid elongation. Thereby,
CC       it may participate in the production of VLCFAs of different chain
CC       lengths that are involved in multiple biological processes as
CC       precursors of membrane lipids and lipid mediators. May also catalyze
CC       the transformation of estrone (E1) into estradiol (E2) and play a role
CC       in estrogen formation. {ECO:0000250|UniProtKB:Q53GQ0}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a very-long-chain (3R)-3-hydroxyacyl-CoA + NADP(+) = a very-
CC         long-chain 3-oxoacyl-CoA + H(+) + NADPH; Xref=Rhea:RHEA:48680,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:57783, ChEBI:CHEBI:58349,
CC         ChEBI:CHEBI:85440, ChEBI:CHEBI:90725; EC=1.1.1.330;
CC         Evidence={ECO:0000250|UniProtKB:Q53GQ0};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=17beta-estradiol + NAD(+) = estrone + H(+) + NADH;
CC         Xref=Rhea:RHEA:24612, ChEBI:CHEBI:15378, ChEBI:CHEBI:16469,
CC         ChEBI:CHEBI:17263, ChEBI:CHEBI:57540, ChEBI:CHEBI:57945; EC=1.1.1.62;
CC         Evidence={ECO:0000250|UniProtKB:Q53GQ0};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=17beta-estradiol + NADP(+) = estrone + H(+) + NADPH;
CC         Xref=Rhea:RHEA:24616, ChEBI:CHEBI:15378, ChEBI:CHEBI:16469,
CC         ChEBI:CHEBI:17263, ChEBI:CHEBI:57783, ChEBI:CHEBI:58349; EC=1.1.1.62;
CC         Evidence={ECO:0000250|UniProtKB:Q53GQ0};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=3-oxooctadecanoyl-CoA + H(+) + NADPH = (3R)-
CC         hydroxyoctadecanoyl-CoA + NADP(+); Xref=Rhea:RHEA:39151,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:57783, ChEBI:CHEBI:58349,
CC         ChEBI:CHEBI:71407, ChEBI:CHEBI:76374;
CC         Evidence={ECO:0000250|UniProtKB:Q53GQ0};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(7Z,10Z,13Z,16Z)-3-oxodocosatetraenoyl-CoA + H(+) + NADPH =
CC         (3R)-hydroxy-(7Z,10Z,13Z,16Z)-docosatetraenoyl-CoA + NADP(+);
CC         Xref=Rhea:RHEA:39323, ChEBI:CHEBI:15378, ChEBI:CHEBI:57783,
CC         ChEBI:CHEBI:58349, ChEBI:CHEBI:73852, ChEBI:CHEBI:76415;
CC         Evidence={ECO:0000250|UniProtKB:Q53GQ0};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(7Z,10Z,13Z,16Z,19Z)-3-oxodocosapentaenoyl-CoA + H(+) + NADPH
CC         = (3R)-hydroxy-(7Z,10Z,13Z,16Z,19Z)-docosapentaenoyl-CoA + NADP(+);
CC         Xref=Rhea:RHEA:39459, ChEBI:CHEBI:15378, ChEBI:CHEBI:57783,
CC         ChEBI:CHEBI:58349, ChEBI:CHEBI:73863, ChEBI:CHEBI:76460;
CC         Evidence={ECO:0000250|UniProtKB:Q53GQ0};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(8Z,11Z,14Z)-3-oxoeicosatrienoyl-CoA + H(+) + NADPH = (3R)-
CC         hydroxy-(8Z,11Z,14Z)-eicosatrienoyl-CoA + NADP(+);
CC         Xref=Rhea:RHEA:39311, ChEBI:CHEBI:15378, ChEBI:CHEBI:57783,
CC         ChEBI:CHEBI:58349, ChEBI:CHEBI:71481, ChEBI:CHEBI:76411;
CC         Evidence={ECO:0000250|UniProtKB:Q53GQ0};
CC   -!- PATHWAY: Lipid metabolism; fatty acid biosynthesis.
CC       {ECO:0000250|UniProtKB:Q53GQ0}.
CC   -!- PATHWAY: Steroid biosynthesis; estrogen biosynthesis.
CC       {ECO:0000250|UniProtKB:Q53GQ0}.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000250|UniProtKB:Q53GQ0}; Multi-pass membrane protein
CC       {ECO:0000250|UniProtKB:Q53GQ0}.
CC   -!- DOMAIN: The di-lysine motif confers endoplasmic reticulum localization
CC       for type I membrane proteins. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the short-chain dehydrogenases/reductases (SDR)
CC       family. 17-beta-HSD 3 subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAD00504.1; Type=Frameshift; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U81186; AAD00504.1; ALT_FRAME; mRNA.
DR   EMBL; BC061543; AAH61543.1; -; mRNA.
DR   RefSeq; NP_114455.1; NM_032066.1.
DR   RefSeq; XP_006234661.1; XM_006234599.3.
DR   AlphaFoldDB; Q6P7R8; -.
DR   SMR; Q6P7R8; -.
DR   BioGRID; 249879; 1.
DR   STRING; 10116.ENSRNOP00000012806; -.
DR   iPTMnet; Q6P7R8; -.
DR   PhosphoSitePlus; Q6P7R8; -.
DR   SwissPalm; Q6P7R8; -.
DR   jPOST; Q6P7R8; -.
DR   PaxDb; 10116-ENSRNOP00000012806; -.
DR   Ensembl; ENSRNOT00000012806.8; ENSRNOP00000012806.4; ENSRNOG00000009630.9.
DR   Ensembl; ENSRNOT00065043310; ENSRNOP00065035506; ENSRNOG00065025150.
DR   GeneID; 84013; -.
DR   KEGG; rno:84013; -.
DR   UCSC; RGD:708367; rat.
DR   AGR; RGD:708367; -.
DR   CTD; 51144; -.
DR   RGD; 708367; Hsd17b12.
DR   eggNOG; KOG1014; Eukaryota.
DR   GeneTree; ENSGT00940000154860; -.
DR   InParanoid; Q6P7R8; -.
DR   OMA; LVAPGMM; -.
DR   OrthoDB; 6845at2759; -.
DR   PhylomeDB; Q6P7R8; -.
DR   TreeFam; TF314591; -.
DR   Reactome; R-RNO-193048; Androgen biosynthesis.
DR   Reactome; R-RNO-75876; Synthesis of very long-chain fatty acyl-CoAs.
DR   UniPathway; UPA00094; -.
DR   UniPathway; UPA00769; -.
DR   PRO; PR:Q6P7R8; -.
DR   Proteomes; UP000002494; Chromosome 3.
DR   Bgee; ENSRNOG00000009630; Expressed in liver and 20 other cell types or tissues.
DR   ExpressionAtlas; Q6P7R8; baseline and differential.
DR   GO; GO:0005783; C:endoplasmic reticulum; IBA:GO_Central.
DR   GO; GO:0031012; C:extracellular matrix; ISO:RGD.
DR   GO; GO:0009923; C:fatty acid elongase complex; ISO:RGD.
DR   GO; GO:0005518; F:collagen binding; ISO:RGD.
DR   GO; GO:0004303; F:estradiol 17-beta-dehydrogenase [NAD(P)+] activity; IEA:UniProtKB-EC.
DR   GO; GO:0001968; F:fibronectin binding; ISO:RGD.
DR   GO; GO:0008201; F:heparin binding; ISO:RGD.
DR   GO; GO:0016491; F:oxidoreductase activity; IBA:GO_Central.
DR   GO; GO:0141040; F:very-long-chain 3-oxoacyl-CoA reductase activity; ISO:RGD.
DR   GO; GO:0006703; P:estrogen biosynthetic process; IEA:UniProtKB-UniPathway.
DR   GO; GO:0030198; P:extracellular matrix organization; ISO:RGD.
DR   GO; GO:0019367; P:fatty acid elongation, saturated fatty acid; ISO:RGD.
DR   GO; GO:0010811; P:positive regulation of cell-substrate adhesion; ISO:RGD.
DR   CDD; cd05356; 17beta-HSD1_like_SDR_c; 1.
DR   Gene3D; 3.40.50.720; NAD(P)-binding Rossmann-like Domain; 1.
DR   InterPro; IPR036291; NAD(P)-bd_dom_sf.
DR   InterPro; IPR020904; Sc_DH/Rdtase_CS.
DR   InterPro; IPR002347; SDR_fam.
DR   InterPro; IPR051019; VLCFA-Steroid_DH.
DR   PANTHER; PTHR43899; RH59310P; 1.
DR   PANTHER; PTHR43899:SF14; VERY-LONG-CHAIN 3-OXOACYL-COA REDUCTASE; 1.
DR   Pfam; PF00106; adh_short; 1.
DR   PIRSF; PIRSF000126; 11-beta-HSD1; 1.
DR   PRINTS; PR00081; GDHRDH.
DR   PRINTS; PR00080; SDRFAMILY.
DR   SUPFAM; SSF51735; NAD(P)-binding Rossmann-fold domains; 1.
DR   PROSITE; PS00061; ADH_SHORT; 1.
PE   2: Evidence at transcript level;
KW   Endoplasmic reticulum; Lipid biosynthesis; Lipid metabolism; Membrane;
KW   NADP; Oxidoreductase; Reference proteome; Steroid biosynthesis;
KW   Transmembrane; Transmembrane helix.
FT   CHAIN           1..312
FT                   /note="Very-long-chain 3-oxoacyl-CoA reductase"
FT                   /id="PRO_0000248370"
FT   TRANSMEM        4..24
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        182..202
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        271..291
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   MOTIF           308..312
FT                   /note="Di-lysine motif"
FT                   /evidence="ECO:0000250"
FT   ACT_SITE        202
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU10001"
FT   BINDING         50..79
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0000250"
FT   BINDING         189
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   CONFLICT        236
FT                   /note="A -> S (in Ref. 1; AAD00504)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   312 AA;  34841 MW;  8531943458EFC711 CRC64;
     MERALPAAGF LYWVGASTIA YLTLRASYSL FRAFQVWCVG NQAFVGPRLG EWAVVTGGTD
     GIGKSYAEEL AKRGMKIVLI SRSQDKLKEV SNNIKEKFNV ETRTIAVDFS LDDIYDKIKT
     GLSGLEIGVL VNNVGMSYEY PEYFLEIPDL DNTIKKLINI NVLSICKVTR LVLPGMVERS
     KGVILNISSA SGMLPVPLLT VYSATKAFVD FFSQCLHEEY KSKGIFVQSV LPFFVATKLA
     KIRKPTLDKP SAETFVKSAI KTVGLQTRTT GYVIHAIMGS INSILPRWIY FKTIMGFNKS
     LRNRYLKKTK KN
//
